The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York of the Federal Food, Drug, and Cosmetic Act (FDCA).* FDA Removes 14 Peptides from Category 2 to Category 1 Mansi Hukmani posted on the topic LinkedIn Sermorelin vs Ipamorelin: Which peptide is right for you? NiceRx FDA approves Ipsen's Iqirvo 'to address unmet need' in primary biliary cholangitis New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,